Reaction
Product Reconstitution Issue reporting signals
As of the last recalculation, Product Reconstitution Issue appears in 315 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is NALTREXONE (PRR 53.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Naltrexone | 23 | 53.1 | 53.1 |
| Botulinum Toxin Type A | 8 | 43.7 | 43.7 |
| Leuprolide Acetate | 23 | 21.1 | 21.1 |